Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00447551
Status:
COMPLETED
Last Update Posted:
2019-11-19
First Post:
2007-03-13
Brief Title:
Canadian Aesthetic Experience With Sculptra Therapy
Sponsor:
Bausch Health Americas Inc
Organization:
Bausch Health Americas Inc
Study Overview
Official Title:
Canadian Study of the Use of Injectable POLY-L-LACTIC Acid Sculptra Therapy in Aesthetic Medicine
Status:
COMPLETED
Status Verified Date:
2019-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Primary objective To evaluate the degree of correction achievable with Sculptra for nasolabial folds mid- and lower facial volume loss jawline laxity and other signs of facial ageing
To document the types and incidence of device-related adverse events with Sculptra
To document the types and incidence of device-related adverse events with Sculptra
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None